August 2014 – Drexel College of Medicine researchers Alessandro Fatatis and Joseph Salvino have developed a compound that helps prevent the metastatic spread of certain cancers, such as breast cancer and prostate cancer. Metastatic cancers are cancers that find a way to spread from one organ to another, and many are incurable. They are currently developing a new version of the compound to prepare it for clinical trials.
Fatatis, a professor of the college’s Department of Pharmacology and Physiology, also holds a leadership position in the Sidney Kimmel Cancer Center at Thomas Jefferson University. His lab developed the compound and specializes in experimental oncology.
